Decades of glyphosate use, and the workers who paid the price.
The world's most widely used herbicide has been the subject of sustained litigation over its association with non-Hodgkin lymphoma.
- 125,000
- Claims filed
- $10B+ in settlements
- Recovered to date
- 2
- Studies cited
Quick eligibility check
Step 1 of 3
Were you exposed to or treated with this product?
Confidential. No fee unless compensation is recovered.
Overview
Roundup, formulated with glyphosate, became the dominant herbicide worldwide. In 2015, the International Agency for Research on Cancer classified glyphosate as a probable human carcinogen, and subsequent litigation has produced significant verdicts and settlements concerning non-Hodgkin lymphoma among long-term users.
Who may qualify
- Diagnosed with non-Hodgkin lymphoma (NHL) or another qualifying cancer
- Regular use of Roundup or other glyphosate-based herbicide — typically as an agricultural, landscaping, or groundskeeping worker
- Exposure over an extended period rather than occasional residential use
- Diagnosis within the filing window permitted by your state's limitations period
Documented injuries & conditions
Medical studies & evidence
IARC Monograph 112: Glyphosate
IARC Monographs · 2015
Glyphosate Use and Cancer Risk
Journal of the National Cancer Institute · 2025
Litigation updates
2026-02-20
Litigation continues in state courts
Courts continue to apply state-specific failure-to-warn standards, and claims in several states proceed on separate theories.
Frequently asked questions
A settlement program was established for qualifying NHL cases, but individual lawsuits continue to be filed based on the facts of each exposure and the law of each state.
Your Roundup (Glyphosate) Exposure claim may still be viable.
Limitations periods vary by state and by claim type. A three-minute review confirms whether your file is still within the filing window.